TAYSHA GENE THERAPIES
Taysha Gene Therapies is a developer of treatments to eradicate severe & life-threatening monogenic diseases of the central nervous system. Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we are able to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to quickly and efficiently build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications.
TAYSHA GENE THERAPIES
Industry:
Biotechnology Genetics Life Science
Founded:
2020-01-01
Address:
Dallas, Texas, United States
Country:
United States
Website Url:
http://www.tayshagtx.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
543 M USD
Technology used in webpage:
IPv6 Pound Sterling COVID-19 Akamai Hosted
Similar Organizations
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Trinity Capital
Trinity Capital investment in Post-IPO Debt - Taysha Gene Therapies
Octagon Capital Advisors
Octagon Capital Advisors investment in Post-IPO Equity - Taysha Gene Therapies
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Taysha Gene Therapies
Acuta Capital Partners
Acuta Capital Partners investment in Post-IPO Equity - Taysha Gene Therapies
RTW Investments
RTW Investments investment in Post-IPO Equity - Taysha Gene Therapies
B Capital
B Capital investment in Post-IPO Equity - Taysha Gene Therapies
GordonMD Global Investments
GordonMD Global Investments investment in Post-IPO Equity - Taysha Gene Therapies
PBM Capital Group
PBM Capital Group investment in Post-IPO Equity - Taysha Gene Therapies
Invus
Invus investment in Post-IPO Equity - Taysha Gene Therapies
Kynam Capital Management
Kynam Capital Management investment in Post-IPO Equity - Taysha Gene Therapies
Key Employee Changes
| Date | New article |
|---|---|
| 2022-12-16 | Taysha Gene Therapies Announces Executive Leadership Changes |
Official Site Inspections
http://www.tayshagtx.com Semrush global rank: 2.29 M Semrush visits lastest month: 8.64 K
Unable to get host informations!!!
More informations about "Taysha Gene Therapies"
About Us - Taysha GTx
Mar 13, 2024 Taysha Gene Therapies is singularly focused on discovering, developing and commercializing gene therapies for the treatment of monogenic diseases of the central …See details»
Patients & Caregivers - Taysha GTx
Patients, caregivers and families of those affected by rare CNS diseases are the foundation for everything we do. We are committed to understanding the unique challenges faced by patients …See details»
Taysha Gene Therapies - LinkedIn
Taysha Gene Therapies | 18,160 followers on LinkedIn. Taysha Gene Therapies is focused on advancing AAV-based gene therapies for severe monogenic diseases of the CNS. | Taysha …See details»
Taysha Gene Therapies - Crunchbase Company Profile …
Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.See details»
Taysha Gene Therapies Reports Third Quarter 2024 Financial …
Nov 13, 2024 The Company’s management team has proven experience in gene therapy development and commercialization. Taysha leverages this experience, its manufacturing …See details»
Taysha Gene Therapies Announces Executive Leadership Changes
DALLAS, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and …See details»
Taysha Gene Therapies - ContactOut
Who is the CEO of Taysha Gene Therapies? Melissa A Ellis is the CEO of Taysha Gene Therapies. To contact Melissa A Ellis email at [email protected].See details»
Taysha Gene Therapies Expands Leadership Team to Deepen …
Dec 29, 2020 DALLAS -- (BUSINESS WIRE)--Dec. 29, 2020-- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric gene therapy company focused on developing and …See details»
Taysha Gene Therapies Provides Update on Deprioritized Pipeline …
DALLAS, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (“Taysha” or “the Company”), a clinical-stage gene therapy company focused on developing …See details»
Taysha Gene Therapies Continues to Add Significant Gene Therapy ...
Mr. Douros will lead all aspects of the company’s legal organization. Ms. Porter will oversee all aspects of human resources, including operations, talent acquisition and employee …See details»
Our Science - Taysha GTx
Our approach aims to address unique challenges in gene therapy by bringing together advanced genetic medicine technologies with established tools.See details»
Taysha Gene Therapies - ZoomInfo
Jun 6, 2024 View Taysha Gene Therapies (www.tayshagtx.com) location in Texas, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Release Details - Taysha Gene Therapies
Nov 12, 2020 DALLAS -- (BUSINESS WIRE)--Nov. 12, 2020-- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric gene therapy company focused on developing and …See details»
Taysha Gene Therapies Provides Update on Deprioritized
Feb 15, 2024 For more information, please visit www.tayshagtx.com. This press release contains forward-looking statements within the meaning of the Private Securities Litigation …See details»
Release Details - Taysha Gene Therapies
Aug 16, 2021 DALLAS -- (BUSINESS WIRE)--Aug. 16, 2021-- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on …See details»
Pipeline - Taysha GTx
Taysha has a pipeline of early-stage gene therapy programs targeting CNS diseases that we may progress in the future or advance through potential partnerships. We have deprioritized the …See details»
Taysha Gene Therapies | Dallas TX | Facebook
Taysha Gene Therapies, Dallas, Texas. 220 likes · 2 talking about this. Biotechnology CompanySee details»
Release Details - ir.tayshagtx.com
Jan 22, 2024 The presentation will include previously disclosed clinical data from the first two adult patients with stage four Rett syndrome dosed with TSHA-102 in the REVEAL Phase 1/2 …See details»
Taysha Gene Therapies Announces Support of Rare Disease Day …
Feb 26, 2021 Launches #RareAlly initiative to recognize those in the rare disease community who inspire and motivate us each day Furthers efforts by patient advocacy groups to educate …See details»